Financial Performance - In 2023, the company's operating revenue decreased by 19.41% year-on-year to approximately ¥225.49 million[22]. - The net profit attributable to shareholders fell by 32.48% year-on-year to approximately ¥30.61 million[22]. - The basic and diluted earnings per share dropped by 50.00% year-on-year to ¥0.40[22]. - The net cash flow from operating activities was negative at approximately -¥38.98 million[22]. - The total profit for the period was 28.55 million yuan, down 43.15% year-on-year[33]. - The net profit after deducting non-recurring gains and losses decreased by 96.43% year-on-year to approximately ¥1.41 million[22]. - The weighted average return on equity decreased by 5.70 percentage points to 1.80%[22]. - Total assets at the end of 2023 were approximately ¥1.94 billion, a decrease of 2.89% from the previous year[22]. - The net assets attributable to shareholders increased slightly by 0.57% to approximately ¥1.70 billion[22]. - The company reported a significant decline in quarterly performance, with a net profit of ¥31.21 million in Q4 after losses in the first three quarters[25]. Research and Development - The company's R&D expenditure as a percentage of operating revenue increased by 7.64 percentage points to 23.11%[23]. - Research and development (R&D) investment increased to 52.11 million yuan, representing a growth of 20.40% compared to the previous year[34]. - The total R&D investment for the year reached ¥52,112,406.45, an increase of 20.40% compared to ¥43,283,159.45 in the previous year[87]. - R&D investment accounted for 23.11% of total revenue, up by 7.64 percentage points from 15.47% in the previous year[87]. - The company has established a dedicated R&D team to tackle autonomous navigation challenges in complex scenarios, continuously increasing investment in key technology breakthroughs[38]. - The company has developed a comprehensive multi-source fusion autonomous positioning and navigation technology system, integrating AI algorithms and various sensor data to achieve intelligent functions such as map construction and obstacle avoidance in complex environments[39]. - The company has developed advanced technologies in military robotics, including high-efficiency human-machine collaboration and control technologies[82]. - The company has made significant advancements in military simulation technology, including the development of a combat simulation training system that received the highest technical score in a competitive bidding process[72]. Market and Product Development - The company is actively investing in emerging technologies, including radar and communication systems, with initial prototypes developed for phased array radar antennas and satellite communication[41]. - The company has developed a series of ground robots and unmanned vehicles with payload capacities ranging from 5kg to 1.5T, focusing on reconnaissance, bomb disposal, and multi-purpose applications[70]. - The company is focusing on enhancing product intelligence and expanding its product range in the "intelligent sensing + robotics" sector[122]. - The company plans to adjust its product classification for 2023 to better reflect its business focus and market trends[122]. - The company is actively developing civilian markets for intelligent robots and sensing equipment, targeting various industries such as emergency rescue, security patrol, industrial inspection, and medical rehabilitation[161]. - The company has launched a series of autonomous positioning and navigation products for robots and drones, including modules for obstacle avoidance and high-altitude positioning, enhancing operational capabilities in various platforms[48]. Corporate Governance and Management - The company has maintained a consistent leadership structure with no changes in key management personnel during the reporting period[170]. - The total pre-tax compensation for the chairman, Chen Bo, was 658,500 CNY for the reporting period[171]. - The total pre-tax compensation for the vice general manager, Wang Xiaobing, was 633,900 CNY for the reporting period[171]. - The total pre-tax compensation for the director, Wang Jin, was 719,900 CNY for the reporting period[171]. - The company has no record of penalties from securities regulatory agencies in the past three years[184]. - The remuneration policies for directors and senior management are based on performance assessments and market averages[182]. - The company held 7 board meetings during the year, with all directors attending in person[187]. Strategic Initiatives - The company plans to invest 10 million in R&D to accelerate innovation in product development[173]. - Future guidance indicates a projected revenue growth of approximately 15% for the next fiscal year[173]. - The company is actively pursuing strategic acquisitions to bolster its competitive position in the market[174]. - A strategic acquisition was completed, enhancing the company's capabilities in R&D and expected to generate $50 million in synergies[176]. - The company is focusing on expanding its market presence and enhancing product offerings through new technology development[174]. Social Responsibility and Community Engagement - The company actively participates in social responsibility initiatives, including national defense education and rural revitalization projects, fostering community engagement[44]. - The company emphasizes collaboration with military foreign trade companies to achieve breakthroughs in military trade products[163].

北京晶品特装科技股份有限公司 关联交易管理制度 （2024 年 4 月修订） 第一章 总则 第一条 为保证北京晶品特装科技股份有限公司（以下简称"公司"）与关联 方之间的关联交易符合公平、公正、公开的原则，确保公司的关联交易行为不损 害公司和非关联股东的合法权益，根据《中华人民共和国公司法》《上市公司信 息披露管理办法》等有关法律、法规、规范性文件及《北京晶品特装科技股份有 限公司章程》（以下简称"《公司章程》"）的有关规定，制定本制度。 第二条 公司与关联方之间的关联交易行为除遵守有关法律、法规、规范性 文件和《公司章程》的规定外，还需遵守本制度的有关规定。 第三条 公司发生关联交易，应当保证关联交易的合法性、必要性、合理性 和公允性，保持公司的独立性，不得利用关联交易调节财务指标，损害公司利益。 第四条 公司的关联交易应当遵循以下基本原则： （一）平等、自愿、等价、有偿的原则； （二）公平、公正、公开的原则。 第五条 公司董事、监事及高级管理人员有义务关注公司是否存在被关联方 挪用资金等侵占公司利益的问题。如发现异常情况，及时提请公司董事会采取相 应措施。 第六条 公司不得直接或者间接向董事、监事、高级管 ...

长江证券承销保荐有限公司 关于北京晶品特装科技股份有限公司 调整部分募集资金投资项目实施地点、内部投资结构并延期的 核查意见 长江证券承销保荐有限公司（以下简称"长江保荐"、"保荐机构"）作为北京 晶品特装科技股份有限公司（以下简称"晶品特装"、"公司"）首次公开发行股票 并上市持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《上市公 司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《上海证券交 易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律法规的规 定，对公司调整部分募集资金投资项目实施地点、内部投资结构并延期进行了审 慎核查，核查情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会 2022 年 9 月 15 日核发的《关于同意北京晶品 特装科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕2133 号），北京晶品特装科技股份有限公司向社会公众公开发行人民币普通股（A 股） 股票 1,900.00 万股（每股面值人民币 1 元），并于 2022 年 12 月 8 日在上海证券 交易所科创板上市（以下简称"本次发行"）。本次发行的发行价格为 6 ...

公司代码：688084 公司简称：晶品特装 北京晶品特装科技股份有限公司 2023 年度内部控制评价报告 北京晶品特装科技股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内 部控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专 项监督的基础上，我们对公司2023年12月31日（内部控制评价报告基准日）的内部控制有效性进行了 评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露 内部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责 组织领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内 容不存在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别 及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整， 提高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目标 提供合理保证。此外，由于情况 ...

北京晶品特装科技股份有限公司 信息披露管理制度 （2024 年 4 月修订） 第一章 总 则 第一条 为加强对北京晶品特装科技股份有限公司（以下简称"公司"）信 息披露工作的管理，促进公司依法规范运作，保护投资者合法权益，规范公司信 息披露行为，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司信息披露管理 办法》、《上海证券交易所科创板股票上市规则》（以下简称"《上市规则》"） 等相关法律、行政法规、规范性文件及《北京晶品特装科技股份有限公司章程》 （"《公司章程》"）的规定，结合公司的具体情况，制定本制度。 第二条 信息披露义务人应当及时依法履行信息披露义务，披露的信息应当 真实、准确、完整，简明清晰、通俗易懂，不得有虚假记载、误导性陈述或者重 大遗漏。 信息披露义务人披露的信息应当同时向所有投资者披露，不得提前向任何单 位和个人泄露。但是，法律、行政法规另有规定的除外。 在内幕信息依法披露前，内幕信息的知情人和非法获取内幕信息的人不得公 开或者泄露该信息，不得利用该信息进行内幕交易。任何单位和个人不得非法要 求信息披露义务人提供依法需 ...

北京晶品特装科技股份有限公司 2023 年度独立董事述职报告—陈湘安 本人作为北京晶品特装科技股份有限公司（以下简称"公司"）的董事会独立 董事，严格按照根据《公司法》《证券法》《上市公司治理准则》《上海证券交易 所科创板股票上市规则》《公司章程》的有关规定，忠实、勤勉独立地履行自身 职责，积极参加各项会议，认真审议董事会各项议案，对公司重大事项发表了独 立意见，现就 2023 年度履职情况，汇报如下： 一、独立董事基本情况 （一）个人工作履历、专业背景以及兼职情况 本人陈湘安，男，1956 年 10 月出生，中国国籍，无境外永久居留权，毕业 于中国人民大学新闻专业。曾任新华社解放军总分社记者、编辑，新华社解放军 分社主办的《世界军事》杂志总编辑，新华社香港分社亚太电视中心主任，上海 新华亚泰电视制作公司执行总裁，北京在线九州信息技术服务有限公司副总裁、 总裁、总编辑、董事长。2022 年 5 月至今任北京在线九州信息技术服务有限公 司董事长、总编辑。2020 年 10 月至今任晶品特装独立董事。 （二）是否存在影响独立性的情况说明 作为公司的独立董事，经自查，本人未在公司担任除独立董事以外的任何职 务，本人 ...

Financial Performance - The company's revenue for Q1 2024 was CNY 8,442,518.45, a decrease of 37.93% compared to the same period last year, primarily due to reduced product deliveries influenced by the military industry situation and execution progress [6]. - The net profit attributable to shareholders was CNY -9,283,701.10, with a basic and diluted earnings per share of CNY -0.12 [5]. - Total operating revenue for Q1 2024 was ¥8,442,518.45, a decrease of 37.6% compared to ¥13,601,286.14 in Q1 2023 [22]. - Net loss for Q1 2024 was ¥10,442,283.14, an improvement from a net loss of ¥11,084,835.28 in Q1 2023 [23]. - Operating profit for Q1 2024 was -¥10,424,664.56, compared to -¥13,353,156.34 in Q1 2023, indicating a narrowing of losses [22]. - Basic and diluted earnings per share for Q1 2024 were both -¥0.12, compared to -¥0.14 in Q1 2023 [23]. Research and Development - The total R&D investment amounted to CNY 11,430,585.55, representing 135.39% of the revenue, an increase of 46.11 percentage points compared to the previous year [6]. - Research and development expenses for Q1 2024 were ¥11,430,585.55, a slight decrease from ¥12,143,453.46 in Q1 2023 [22]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY -41,346,483.24, indicating a decrease in cash received from sales compared to the previous year [5]. - In Q1 2024, the company reported cash inflows from operating activities of CNY 21,873,250.95, a decrease of 54.8% compared to CNY 48,420,983.20 in Q1 2023 [25]. - The company's cash and cash equivalents decreased to CNY 505,472,932.08 from CNY 1,240,689,744.04, indicating a significant reduction of about 59.2% [17]. - The company's cash and cash equivalents at the end of Q1 2024 stood at CNY 493,169,228.08, down from CNY 633,129,375.45 a year earlier [26]. - The total cash outflow for the quarter was CNY -733,501,644.85, a slight improvement from CNY -740,525,591.02 in Q1 2023 [26]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,894,510,605.40, a decrease of 2.12% from the end of the previous year [6]. - The total current assets were reported at CNY 1,616,131,467.94, down from CNY 1,674,077,398.73, reflecting a decrease of approximately 3.5% [18]. - Total liabilities decreased to CNY 1,616,131,467.94 from CNY 1,674,077,398.73, indicating a reduction of approximately 3.5% [18]. - Total liabilities as of Q1 2024 were ¥240,482,310.31, slightly down from ¥241,789,107.59 in the previous year [22]. Shareholder Information - The company has a total of 3,006 common shareholders at the end of the reporting period [10]. - The top three shareholders hold a combined 51.30% of the company's shares, indicating a concentrated ownership structure [11]. - The equity attributable to shareholders decreased by 2.25% to CNY 1,665,185,028.09 compared to the end of the previous year [6]. - Total equity attributable to shareholders was ¥1,665,185,028.09, a decrease from ¥1,703,539,746.92 in Q1 2023 [22]. Operational Metrics - The company experienced a significant decline in sales revenue, with cash received from sales at CNY 15,931,974.55, down 65.9% from CNY 46,688,059.35 in the previous year [25]. - Employee compensation payments increased to CNY 21,498,155.44, up 19.0% from CNY 17,979,819.78 in Q1 2023 [25]. - Tax payments decreased to CNY 7,981,403.34, down 46.3% from CNY 14,883,330.12 in the same quarter last year [25]. Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report [14]. - The company reported a weighted average return on equity of -0.54% for the period [6].

证券代码：688084 证券简称：晶品特装 公告编号：2024-019 北京晶品特装科技股份有限公司 第二届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 北京晶品特装科技股份有限公司（以下简称"公司"）第二届董事会第五次会 议于 2024 年 4 月 13 日以通讯方式发出会议通知，并于 2024 年 4 月 23 日在公 司会议室以现场表决的方式召开。会议应出席董事 9 人，实际出席董事 9 人，公 司监事及高级管理人员均列席会议。会议由董事长陈波先生主持。会议的召集和 召开程序符合《中华人民共和国公司法》等法律、法规、部门规章以及《北京晶 品特装科技股份有限公司章程》（以下简称《公司章程》）的有关规定，会议作 出的决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于 2023 年度总经理工作报告的议案》 经审议，2023 年度公司总经理陈波先生严格按照《公司法》等有关法律、法 规、规章和《公司章程》《总经理工作细则》的规定和要求，认真贯彻执行股东 大会通过的各项 ...

北京晶品特装科技股份有限公司 公司三位独立董事陈湘安先生、吕鹏先生、李奔先生，均未在公司担任除 独立董事以外的任何职务，也未在公司控股股东或关联方单位担任职务，与公 司、控股股东和其他关联方之间不存在利害关系或其他可能妨碍其进行独立客 观判断的关系。 公司董事会认为，三位独立董事符合《上市公司独立董事管理办法》《上海 证券交易所上市公司自律监管指引第 1 号—规范运作》等法律法规中关于独立 董事任职资格及独立性要求，不存在任何妨碍其进行独立客观判断的关系，也 不存在影响独立性的情况。 北京晶品特装科技股份有限公司董事会 2024 年 4 月 23 日 董事会关于独立董事独立性自查情况的专项报告 根据《上市公司独立董事管理办法》《上海证券交易所上市公司自律监管指 引第 1 号—规范运作》等要求，并结合三位独立董事出具的《独立董事关于独 立性情况的自查报告》及其任职履历、现职关系等，针对公司三位独立董事独 立性情况，总体评估如下： ...

北京晶品特装科技股份有限公司 募集资金存放与使用情况鉴证报告 大华核字[2024]0011010695 号 大华会计师事务所(特殊普通合伙) Da Hua Certified Public Accountants (Special General Partnership ) ： 北京晶品特装科技股份有限公司 募集资金存放与使用情况鉴证报告 （2023 年度） | | 目 录 | 页 次 | | --- | --- | --- | | r | 募集资金存放与使用情况鉴证报告 | 1-2 | | = | 北京晶品特装科技股份有限公司 2023 年度募 | 1-6 | | | 集资金存放与实际使用情况的专项报告 | | 募 集 资 金 存 放 与 使 用 情 况 鉴 证 报 告 大华核字[2024]0011010695 号 北京晶品特装科技股份有限公司全体股东: 我们审核了后附的北京晶晶特装科技股份有限公司(以下简称 "晶品特装")《2023年度募集资金存放与实际使用情况的专项报 告》(以下简称"募集资金专项报告")。 一、董事会的责任 晶品特装董事会的责任是按照中国证券监督管理委员会《上市公 司监管指引第2号 - ...